1203651-07-3

Basic information

• Product Name: (3S,5R)-3-(Boc-aMino)-5-Methylpiperidine
• Synonyms: (3S,5R)-3-(Boc-aMino)-5-Methylpiperidine;tert-butyl N-[(3S,5R)-5-methylpiperidin-3-yl]carbamate;tert-Butyl ((3S,5R)-5-methylpiperidin-3-yl)carbamate;CARBAMIC ACID, N-[(3S,5R)-5-METHYL-3-PIPERIDINYL]-, 1,1-DIMETHYLETHYL ESTER(WX601051)
• CAS NO: 1203651-07-3
• Molecular Formula: C11H22N2O2
• Molecular Weight: 214.30458
• Mol File: 1203651-07-3.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: (3S,5R)-3-(Boc-aMino)-5-Methylpiperidine(CAS DataBase Reference)
• NIST Chemistry Reference: (3S,5R)-3-(Boc-aMino)-5-Methylpiperidine(1203651-07-3)
• EPA Substance Registry System: (3S,5R)-3-(Boc-aMino)-5-Methylpiperidine(1203651-07-3)

Safety Data

• Hazardous Substances Data: 1203651-07-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(3S,5R)-3-(Boc-aMino)-5-Methylpiperidine is used as a synthetic intermediate for the preparation of pyridinamine compounds. These compounds act as Pim kinase inhibitors, which are important in the treatment of diseases related to the activity of Pim kinases, such as cancer and other diseases. By inhibiting the activity of Pim kinases, these pyridinamine compounds can help regulate cell growth and division, potentially leading to the suppression of tumor growth and the treatment of cancer.

Upstream product

• 631910-23-1 tert-butyl N-(5-methylpyridin-3-yl)carbamate 
• 3430-19-1 5-methylpyridin-3-amine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1203651-05-1 (2S,4R)-methanesulfonic acid 2-tert-butoxycarbonylamino-5-methanesulfonyloxy-4-methyl-pentyl ester 
• 74936-93-9 (S)-5-oxopyrrolidine-2-carbonyl chloride 
• 4931-66-2 methyl (S)-pyroglutamate 
• 951163-64-7 tert-butyl [(1S,3R)-4-hydroxy-1-(hydroxymethyl)-3-methylbutyl]carbamate 
• 196394-49-7 (2S,4R)-1-(tert-butyl) 2-methyl 4-methyl-5-oxopyrrolidine-1,2-dicarboxylate 
• 108963-96-8 (S)-1-tert-butoxycarbonyl-5-methoxycarbonyl-pyrrolidin-2-one 
• 98-79-3 L-Pyroglutamic acid 
• 1203651-06-2 tert-butyl [(3S,5R)-1-benzyl-5-methylpiperidin-3-yl]carbamate 

Downstream Products

• 1620240-26-7 benzyl [2-{[(4-{(3S,5R)-3-[(tert-butoxycarbonyl)amino]-5-methylpiperidin-1-yl}pyridin-3-yl)amino]carbonyl}-7-(4-methylpiperazin-1-yl)quinolin-3-yl]carbamate 
• 1620240-40-5 benzyl (7-bromo-2-{[(4-{(3S,5R)-3-[(tert-butoxycarbonyl)amino]-5-methylpiperidin-1-yl}pyridin-3-yl)amino]carbonyl}quinolin-3-yl)carbamate 
• 1620240-52-9 benzyl [2-{[(4-{(3S,5R)-3-[(tert-butoxycarbonyl)amino]-5-methylpiperidin-1-yl}pyridin-3-yl)amino]carbonyl}-7-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)quinolin-3-yl]carbamate 
• 1620240-60-9 benzyl [2-{[(4-{(3S,5R)-3-[(tert-butoxycarbonyl)amino]-5-methylpiperidin-1-yl}pyridin-3-yl)amino]carbonyl}-7-(2-oxopiperidin-1-yl)quinolin-3-yl]carbamate 
• 1620240-63-2 benzyl [2-{[(4-{(3S,5R)-3-[(tert-butoxycarbonyl)amino]-5-methylpiperidin-1-yl}pyridin-3-yl)amino]carbonyl}-7-(4-methyl-3-oxopiperazin-1-yl)quinolin-3-yl]carbamate 
• 1620240-67-6 benzyl [2-[({4-[(3S,5R)-3-amino-5-methylpiperidin-1-yl]pyridin-3-yl}amino)carbonyl]-7-(3-oxopiperazin-1-yl)quinolin-3-yl]carbamate 
• 1620240-74-5 benzyl [2-[({4-[(3S,5R)-3-amino-5-methylpiperidin-1-yl]pyridin-3-yl}amino)carbonyl]-7-(3-oxomorpholin-4-yl)quinolin-3-yl]carbamate 
• 1620240-14-3 benzyl (2-{[(4-{(3S,5R)-3-[(tert-butoxycarbonyl)amino]-5-methylpiperidin-1-yl}pyridin-3-yl)amino]carbonyl}-7-morpholin-4-ylquinolin-3-yl)carbamate 

Relevant articles and documents

BICYCLIC HETEROAROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS

The present disclosure describes bicyclic heteroaromatic carboxamide derivatives of formula (I), as well as their compositions and methods of use. The compounds inhibit the activity of the Pim kinases, and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases.

PYRIDINEAMINE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS

The present disclosure describes pyridineamine compounds, as well as their compositions and methods of use. The compounds inhibit the activity of the Pim kinases, and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer, immune disorders and other diseases. Formula (I).

BICYCLIC AROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS

The present disclosure describes bicyclic aromatic carboxamide derivatives, as well as their compositions and methods of use. The compounds inhibit the activity of the Pim kinases, and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases.

SELECTIVELY SUBSTITUTED QUINOLINE COMPOUNDS

Embodiments of the disclosure relate to selectively substituted quinoline compounds of formula (I) that act as antagonists or inhibitors for Toll -like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic

FURO- AND THIENO-PYRIDINE CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS

The present disclosure describes furo- and thieno-pyridine carboxamide compounds, as well as their compositions and methods of use. The compounds inhibit the activity of the Pim kinases, and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases.

THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS

The present disclosure describes thiazole and pyridine carboxamide derivatives, their compositions and methods of use. The compounds inhibit the activity of the Pim kinases and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases.

BICYCLIC AROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS

The present disclosure describes bicyclic aromatic carboxamide derivatives, as well as their compositions and methods of use. The compounds inhibit the activity of the Pim kinases, and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases.

ANTIBIOTIC DRUG

This invention relates to a malic acid salt of (3S, 5R)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid. Also disclosed is a method of treating bacterial infection by an effective amount of this salt.